NantKwest stock: buy or sell?
May 14th, 2020
NantKwest, Inc., a clinical-stage immunotherapy biotechnology company, develops immunotherapeutic treatments for cancer, infectious diseases, and inflammatory diseases in the United States.
Should I buy NantKwest stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, NantKwest stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is NantKwest stock a buy?
Banks and financial institutions publish stock ratings everyday.Unfortunately, we couldn't detect any rating for NK stock for the last month.
NantKwest stock analysis
NantKwest skyrocketed an outstanding 5.53% and closed at $5.15.
NantKwest closed today at $5.15 and skyrocketed an outstanding 5.53%. From a daily perspective, NK is in a short term uptrend after plotting its last bottom ($3.49, on May 1st) higher than the previous bottom, and its last top ($5.54, on Monday) also over the previous top. Now trading in between its last bottom and last top NK might consolidate in a plain range, waiting to break out over $5.54 or down under $3.49. Since price and SMA100d lines crossed up on Monday, NK climbed $0.92 (21.75%).
NantKwest shares skyrocketed 21.75% this week, ending at $5.15. Late March NK collapsed a bloodcurdling -21.15% in just one week. With this, it's been 5 climbing weeks in a row, soaring a 83.08%.
NantKwest is in a glaring downtrend, marking consecutive declining peaks and bottoms. Now is trading in between the - range. There is a chance to rebound and reverse this situation if price can hold above the level. Early April NK price bounced up over the SMA of 40 weeks that acted as support stopping new slides. Late October 2019, SMA20w and SMA40w crossed up triggering a rise of 343.97%.
NantKwest stock price history
NantKwest IPO was on July 28th, 2015 at $37.00 per share1. Since then, NK stock declined a -86.10%, with a yearly average of -21.50%.
1: Adjusted price after possible price splits or reverse-splits.
NantKwest stock historical price chart
NK stock reached 52-week highs on January at $9.90, and all-time highs 2015-07-28 with a price of 38.48.
NantKwest stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we have not found any price forecast for NantKwest stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report , NantKwest . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw a beatiful growth of 4.44% to $0.05 million USD. When comparing 2018 vs 2017, instead, profit margin (that is, the net income divided by revenues) rocketed a 9,537.16% to -204,736.17%.
|2013||$0.60 M||-||$-2.05 M-341.7%||-|
|2014||$0.64 M||6.83%||$-6.21 M-969.3%||203.07%|
|2015||$0.24 M||-63.18%||$-236.88 M-100371.2%||3,712.59%|
|2016||$0.04 M||-81.36%||$-120.81 M-274565.9%||-49.00%|
|2017||$0.05 M||2.27%||$-96.42 M-214273.3%||-20.19%|
|2018||$0.05 M||4.44%||$-96.23 M-204736.2%||-0.20%|
Quarterly financial resultsNantKwest reported $0.01 M in sales for 2018-Q4, a -77.42% decline compared to previous quarter. Reported quarter income marked $-17.34 M with a profit margin of -247,714.29%. Profit margin plummed a -171,472.35% compared to previous quarter when profit margin was -76,241.94%. When comparing sales to same quarter last year, NantKwest sales marked a bloodcurdling loss and collapsed a -41.67%.
|2017-Q1||$0.01 M||-||$-24.52 M-222909.1%||-|
|2017-Q2||$0.01 M||27.27%||$-23.45 M-167500.0%||-4.36%|
|2017-Q3||$0.01 M||-42.86%||$-23.97 M-299612.5%||2.21%|
|2017-Q4||$0.01 M||50.00%||$-24.49 M-204058.3%||2.16%|
|2018-Q1||$0.01 M||-58.33%||$-27.52 M-550380.0%||12.38%|
|2018-Q2||$0.00 M||-20.00%||$-27.73 M-693300.0%||0.77%|
|2018-Q3||$0.03 M||675.00%||$-23.64 M-76241.9%||-14.77%|
|2018-Q4||$0.01 M||-77.42%||$-17.34 M-247714.3%||-26.63%|
NantKwest ownershipWhen you are planning to buy shares of a company, it's worth to check its ownership structure.
NantKwest shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 71.73% of all shares.
In case of NantKwest stock, 5.99% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for NK stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to NantKwest:
|Market cap||$507.3 M|
|Total shares||98.5 M|
|Float shares||34.1 M|
|- Institutional holdings (%)||6.0%|
|- Insider holdings (%)||71.7%|
|Shares in short selling||0.0%|
|Thursday, May 14th, 2020|
|Day range||$4.60 - $5.38|
|Average true range||$0.53|
|50d mov avg||$3.55|
|100d mov avg||$4.50|
|200d mov avg||$2.94|
NantKwest performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We chose as the bechmarking frame for NantKwest stock.